4basebio
4basebio provides innovative technologies and products for gene therapy and vaccine development. Our enzymatic DNA synthesis platform allows for the GMP production of DNA products at unparalleled speed, scale, and purity as compared to pDNA. The proprietary DNA products feed into the production of mRNA, viral vectors and DNA vaccine technologies. 4basebio’s targeted, non-viral delivery platform, Hermes™, allows targeting towards specific cells or tissues of interest, and is suitable for a range of nucleic acid and biological payloads. Together, these platform technologies can greatly accelerate the development of gene therapy and vaccine programmes.Content by 4basebio
| 4 min read
Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
